93 related articles for article (PubMed ID: 8694361)
41. Spatial and temporal expression of c-Fos protein in the spinal cord of anesthetized rat induced by subcutaneous bee venom injection.
Luo C; Chen J; Li HL; Li JS
Brain Res; 1998 Sep; 806(2):175-85. PubMed ID: 9739136
[TBL] [Abstract][Full Text] [Related]
42. Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine.
Saadé NE; Abou Jaoude PG; Saadeh FA; Hamoui S; Safieh-Garabedian B; Kanaan SA; Atweh SF; Jabbur SJ
Brain Res; 1997 Sep; 769(1):57-65. PubMed ID: 9374273
[TBL] [Abstract][Full Text] [Related]
43. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
Honoré P; Chapman V; Buritova J; Besson JM
Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
[TBL] [Abstract][Full Text] [Related]
44. Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: role of protein kinase C and N-methyl-D-aspartate receptors.
Song L; Wu C; Zuo Y
BMC Anesthesiol; 2015; 15():12. PubMed ID: 25745356
[TBL] [Abstract][Full Text] [Related]
45. N-Methyl-D-aspartate receptor antagonist d-AP5 prevents pertussis toxin-induced alterations in rat spinal cords by inhibiting increase in concentrations of spinal CSF excitatory amino acids and downregulation of glutamate transporters.
Wong CS; Wu GJ; Chen WF; Jean YH; Hung CH; Lin CS; Huang SY; Wen ZH
Brain Res Bull; 2009 Aug; 80(1-2):69-74. PubMed ID: 19463918
[TBL] [Abstract][Full Text] [Related]
46. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
Stanfa LC; Dickenson AH
Br J Pharmacol; 1993 Apr; 108(4):967-73. PubMed ID: 8485635
[TBL] [Abstract][Full Text] [Related]
47. Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.
Eisenach JC; Gebhart GF
Anesthesiology; 1995 Nov; 83(5):1046-54. PubMed ID: 7486155
[TBL] [Abstract][Full Text] [Related]
48. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
49. Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.
Liu S; Liu WT; Liu YP; Dong HL; Henkemeyer M; Xiong LZ; Song XJ
Cancer Res; 2011 Jul; 71(13):4392-402. PubMed ID: 21555368
[TBL] [Abstract][Full Text] [Related]
50. Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats.
Ito K; Yoshikawa M; Maeda M; Jin XL; Takahashi S; Matsuda M; Tamaki R; Kobayashi H; Suzuki T; Hashimoto A
Eur J Pharmacol; 2008 May; 586(1-3):139-44. PubMed ID: 18384770
[TBL] [Abstract][Full Text] [Related]
51. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
52. NMDA receptors are involved in upstream of the spinal JNK activation in morphine antinociceptive tolerance.
Guo RX; Zhang M; Liu W; Zhao CM; Cui Y; Wang CH; Feng JQ; Chen PX
Neurosci Lett; 2009 Dec; 467(2):95-9. PubMed ID: 19818835
[TBL] [Abstract][Full Text] [Related]
53. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression.
Gogas KR; Levine JD; Basbaum AI
J Pharmacol Exp Ther; 1996 Feb; 276(2):801-9. PubMed ID: 8632353
[TBL] [Abstract][Full Text] [Related]
54. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
[TBL] [Abstract][Full Text] [Related]
55. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157
[TBL] [Abstract][Full Text] [Related]
56. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
57. The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Le Guen S; Honoré P; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM
Brain Res; 1999 Jul; 834(1-2):200-6. PubMed ID: 10407116
[TBL] [Abstract][Full Text] [Related]
58. Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure.
Jin C; Araki H; Nagata M; Suemaru K; Shibata K; Kawasaki H; Hamamura T; Gomita Y
Psychopharmacology (Berl); 2004 Oct; 175(4):428-35. PubMed ID: 15175841
[TBL] [Abstract][Full Text] [Related]
59. Dynamic variations of c-Fos expression in the spinal cord exposed to intramuscular hypertonic saline-induced muscle nociception.
Chen YK; Lei J; Jin L; Tan YX; You HJ
Eur J Pain; 2013 Mar; 17(3):336-46. PubMed ID: 22893527
[TBL] [Abstract][Full Text] [Related]
60. The glycine site-specific NMDA antagonist (+)-HA966 enhances the effect of morphine and reverses morphine tolerance via a spinal mechanism.
Adam F; Dufour E; Le Bars D
Neuropharmacology; 2008 Mar; 54(3):588-96. PubMed ID: 18177675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
